Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Randomized Multicenter Single Blinded Study to Assess the Safety and Efficacy of the SELUTION SLR™ 018 Drug Eluting Balloon in the Treatment of Subjects With Femoropopliteal Artery Lesions

NCT05132361 is registered in ClinicalTrials.gov with M.A. Med Alliance S.A. as lead sponsor.

NCT NCT05132361
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05132361 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Randomized Multicenter Single Blinded Study to Assess the Safety and Efficacy of the SELUTION SLR™ 018 Drug Eluting Balloon in the Treatment of Subjects With Femoropopliteal Artery Lesions
Lead sponsor
M.A. Med Alliance S.A.
Phase
Not applicable
Overall status
Active, not recruiting
Start date
December 1, 2022
Completion date
December 1, 2030
Enrollment
300 (actual)
Sites
38

Conditions

As the registry lists them; a condition with its own page is linked.

peripheral arterial disease, superficial femoral artery stenosis